Andere Sprachen Changzhou Qianhong Biopharma CO.,LTD

Aktien

002550

CNE100001070

002550

Schlusskurs Shenzhen S.E. Andere Börsenplätze 00:00:00 17.05.2024			% 5 Tage	% 1. Jan.
5,8 ^CNY	+0,69 %		+0,69 %	-1,36 %

25.04.	Changzhou Qianhong Biopharma CO.,LTD berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr	CI
22.01.	Changzhou Qianhong Biopharma CO.,LTD billigt Vorstandswahlen	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Changzhou Qianhong Biopharma CO.,LTD Proposes Final Cash Dividend for the Year 2023	26.04.
Changzhou Qianhong Biopharma CO.,LTD Reports Earnings Results for the Full Year Ended December 31, 2023	25.04.
Tranche Update on Changzhou Qianhong Biopharma CO.,LTD's Equity Buyback Plan announced on January 3, 2024.	22.03.
Changzhou Qianhong Biopharma CO.,LTD's Equity Buyback announced on January 3, 2024 has closed with 25,000,000 shares, representing 1.95% for CNY 140.76 million.	22.03.
Changzhou Qianhong Biopharma CO.,LTD Approves Board Elections	22.01.
Changzhou Qianhong Biopharma CO.,LTD announces an Equity Buyback for CNY 170 million worth of its shares.	03.01.
Changzhou Qianhong Biopharma CO.,LTD authorizes a Buyback Plan.	02.01.
Changzhou Qianhong Biopharma CO.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2023	24.10.23
Changzhou Qianhong Biopharma CO.,LTD(XSEC:002550) added to S&P Global BMI Index	18.09.23
Changzhou Qianhong Biopharma CO.,LTD Reports Earnings Results for the Half Year Ended June 30, 2023	21.07.23
Changzhou Qianhong Biopharma Co.,Ltd Announces Cash Dividend on A Shares for 2022, Payable on May 26, 2023	18.05.23
Changzhou Qianhong Biopharma CO.,LTD Approves Cash Dividend for 2022	12.05.23
Tranche Update on Changzhou Qianhong Biopharma CO.,LTD's Equity Buyback Plan announced on April 15, 2023.	19.04.23
Changzhou Qianhong Biopharma CO.,LTD's Equity Buyback announced on April 15, 2023 has closed with 5,000,000 shares, representing 0.39% for CNY 30.09 million.	19.04.23
Changzhou Qianhong Biopharma CO.,LTD Proposes Final Cash Dividend for 2022	17.04.23
Changzhou Qianhong Biopharma CO.,LTD announces an Equity Buyback for CNY 34 million worth of its shares.	14.04.23
Changzhou Qianhong Biopharma CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023	14.04.23
Changzhou Qianhong Biopharma CO.,LTD Reports Earnings Results for the Full Year Ended December 31, 2022	14.04.23
Changzhou Qianhong Biopharma Co.,Ltd authorizes a Buyback Plan.	13.04.23
Changzhou Qianhong Biopharma CO.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2022	26.10.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Changzhou Qianhong Biopharma CO.,LTD

Aktien

002550

CNE100001070

002550

Andere Sprachen

Filter